Protokinetix 

$0.01
6
-$0-3.69% Wednesday 19:48

統計

當日最高
0.01
當日最低
0.01
52週最高
0.03
52週最低
0.01
成交量
141,520
平均成交量
59,426
市值
5.15M
市盈率
-
股息收益率
-
股息
-

收益

31Oct預期
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0
-0
-0
-0
預期每股收益
N/A
實際每股收益
-0.0013

人們還關注

此列表基於在 Stock Events 上關注 PKTX 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Biotechnology
Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.
Show more...
首席執行官
國家
US
ISIN
US7437221002

上市公司